Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Wolski

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|May 23, 2007
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causesSteven E Nissen, Kathy Wolski
Archives of Internal Medicine|July 27, 2010
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortalitySteven E Nissen, Kathy Wolski
JAMA|October 22, 2005
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitusSteven E Nissen, Kathy Wolski, Eric J Topol
Journal of General Internal Medicine|September 15, 2020
Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled TrialMichael Macknin, Kathy Wolski, Jeffrey Negrey, et al.
The American Journal of Cardiology|June 13, 2006
Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary interventionJason O Robertson, A Michael Lincoff, Kathy Wolski, et al.
JAMA|September 13, 2007
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trialsA Michael Lincoff, Kathy Wolski, Stephen J Nicholls, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 26, 2019
Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled TrialDaniel H Solomon, Ming Shao, Kathy Wolski, et al.
Journal of Vascular Surgery|October 3, 2008
Validation of a method for determination of the ankle-brachial index in the seated positionHeather L Gornik, Bobby Garcia, Kathy Wolski, et al.
Atherosclerosis|June 1, 2025
Differential cardiovascular impact of ω-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trialTom Kai Ming Wang, Stephen J Nicholls, Julie St John, et al.
Cardiovascular Diagnosis and Therapy|February 18, 2016
HDL function and subclinical atherosclerosis in juvenile idiopathic arthritisPreethi Mani, Kiyoko Uno, MyNgan Duong, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|May 23, 2007
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causesSteven E Nissen, Kathy Wolski
Archives of Internal Medicine|July 27, 2010
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortalitySteven E Nissen, Kathy Wolski
JAMA|October 22, 2005
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitusSteven E Nissen, Kathy Wolski, Eric J Topol
Journal of General Internal Medicine|September 15, 2020
Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled TrialMichael Macknin, Kathy Wolski, Jeffrey Negrey, et al.
The American Journal of Cardiology|June 13, 2006
Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary interventionJason O Robertson, A Michael Lincoff, Kathy Wolski, et al.
JAMA|September 13, 2007
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trialsA Michael Lincoff, Kathy Wolski, Stephen J Nicholls, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 26, 2019
Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled TrialDaniel H Solomon, Ming Shao, Kathy Wolski, et al.
Journal of Vascular Surgery|October 3, 2008
Validation of a method for determination of the ankle-brachial index in the seated positionHeather L Gornik, Bobby Garcia, Kathy Wolski, et al.
Atherosclerosis|June 1, 2025
Differential cardiovascular impact of ω-3 fatty acid in patients at high cardiovascular risk in Asians versus non-Asians: Sub-analysis of the strength randomized clinical trialTom Kai Ming Wang, Stephen J Nicholls, Julie St John, et al.
Cardiovascular Diagnosis and Therapy|February 18, 2016
HDL function and subclinical atherosclerosis in juvenile idiopathic arthritisPreethi Mani, Kiyoko Uno, MyNgan Duong, et al.
Pageof 13